RN Mobile Menu


Rheumatoid Arthritis

What are my choices when methotrexate fails?

There is an ongoing debate about treatment options for RA patients when methotrexate fails. It usually comes down to two choices:  triple therapy or a biologic? New research shows both are nearly equally effective. (©BurlinghamShutterstock)


Rheumatoid Arthritis

Controlling depressive symptoms in patients with early inflammatory polyarthritis could affect disease outcomes, researchers suggest.

Study shows increased cardiovascular disease risk in RA. Screening and treatment recommended.

In rheumatoid arthritis there is an ongoing debate about what to do when methotrexate fails. Physicians typically have two choices.

Biologics can improve the quality of life for RA patients, but side effects remain a problem, especially for RA patients with co-morbidities.

A $102 test could be the crux between good health and a future of chronic illness for patients with rheumatoid arthritis.

Tumor necrosis factor-a inhibitors are the most widely used first line biologic therapy for the treatment of rheumatoid arthritis, but there have been concerns raised about the safety of these treatments.

Patients with rheumatic disease can have movement and other neurodegenerative disorders that may look like Parkinson’s disease, but looks can be deceiving.


Subscribe to Rheumatoid Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.